Novartis, Bristol Myers halt autoimmune CAR-T trials due to adverse events

Reports

2

Domains carrying it

2

First reported

31 August 2026

Latest report

2 September 2026

◆ Sectors

◆ Where

United States

◆ Timeline

1. 31 August 2026Novartis, Bristol Myers halt autoimmune CAR-T trials due to adverse eventsfiercebiotech.com
2. 2 September 2026Novartis and Bristol Myers Squibb halt clinical trials following serious side effectsmedwatch.com

◆ Connected developments

Situations Wire finds semantically close to this one. Proximity, not cause.

• U.S. FDA Grants Accelerated Approval to Bristol Myers Squibb's First CELMoD Therapy ...12 reports · 12 domains · 17 August 2026
• Pharma giants AstraZeneca and Bristol-Myers in reported merger talks2 reports · 2 domains · 5 August 2026
• Lawmakers urge FDA to enact new China policies after 3 gene therapy deaths5 reports · 4 domains · 3 September 2026
• Novartis Lp(a) drug fails closely watched ph. 3 trial2 reports · 2 domains · 5 September 2026
• BioNTech, Genentech terminate Phase 2 of personalized mRNA cancer vaccine2 reports · 2 domains · 28 August 2026
• Safety concerns spur FDA to again halt testing of Regenxbio gene therapy3 reports · 3 domains · 31 August 2026

◆ Share

◆ Evidence

2 reports · 2 domains

• Novartis and Bristol Myers Squibb halt clinical trials following serious side effectsmedwatch.com · 2 September 2026
• Novartis, Bristol Myers halt autoimmune CAR-T trials due to adverse eventsfiercebiotech.com · 31 August 2026